Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Press Release
Authors: Steve Young, Chief Scientific Officer Sylviane de Viron, Data and Knowledge Manager In the face...
- Press Release
King of Prussia, PA – 6 February 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper...
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Featured Article
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the...
Source: Springer Link
- Press Release
King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions provider, CluePoints, is...
- Press Release
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the...
- Featured Article
Clinical research is in the grips of a revolution that has caused a wave of new...
Source: ACRP
- Press Release
King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
It appears that 2018 is the year CluePoints really established itself as a leader in the...
- Press Release
Successful pilot project prompts strategic partnership that strengthens risk-based monitoring in Japan and places both companies...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
We’re delighted to announce that we’ll be at Partnerships in Clinical Trials next month! You can...
- Press Release
Today, we’re excited to announce that we’ve added an abundance of new features to the CluePoints...
- Press Release
This month, experts from across the globe will gather for CBI’s Global Risk-Based Monitoring event, taking...
- Press Release
Arena International’s flagship event, Outsourcing in Clinical Trials New England, is almost upon us. This year’s...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
The 10th Annual FDA/ADVAMED Medical Devices and Diagnostics Statistical Issues Conference, taking place on April 26,...
- Featured Article
The latest version of the Good Clinical Practice (GCP) quality standard insists that sponsors implement a...
Source: Global Forum
- Featured Article
A risk-based approach to clinical research may include a central statistical assessment of data quality.
...Source: Sage Journals
- Featured Article
Not only is there a significant good clinical practice (GCP) expectation, Risk-Based Monitoring (RBM) presents a...
Source: Contract Pharma
- Featured Article
Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information in a...
Source: Outsourcing Pharma
- Featured Article
Since the introduction of the ICH E6 (R2) addendum, the industry has seen a rise in...
Source: Pharma Focus Asia
- Featured Article
The ICH E6 R2 Addendum is starting to have a significant, positive impact on clinical trial...
Source: Contract Pharma
- Featured Article
In the clinical trials industry there is a tendency to watch and wait, which has been...
Source: PharmaIQ